Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

White House Meth Bill Plan Would Not Put Pseudoephedrine Behind Counters

This article was originally published in The Tan Sheet

Executive Summary

The Bush Administration supports federal meth legislation that would apply significantly fewer restrictions on pseudoephedrine than the pending Talent/Feinstein senate bill

You may also be interested in...



Souder Bill Follows White House Meth Strategy; Highlights Import, Super Labs

Pseudoephedrine importers and exporters would be required to file with the Department of Justice before transferring sale of the meth precursor to a new buyer as part of a bill introduced by Rep. Mark Souder (R-Ind.) Sept. 22

Souder Bill Follows White House Meth Strategy; Highlights Import, Super Labs

Pseudoephedrine importers and exporters would be required to file with the Department of Justice before transferring sale of the meth precursor to a new buyer as part of a bill introduced by Rep. Mark Souder (R-Ind.) Sept. 22

Souder Bill Follows White House Meth Strategy; Highlights Import, Super Labs

Pseudoephedrine importers and exporters would be required to file with the Department of Justice before transferring sale of the meth precursor to a new buyer as part of a bill introduced by Rep. Mark Souder (R-Ind.) Sept. 22

Related Content

Topics

UsernamePublicRestriction

Register

PS098572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel